Vanguard Group Inc. lifted its holdings in National Health Investors, Inc. (NYSE:NHI – Free Report) by 0.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 6,173,352 shares of the real estate investment trust’s stock after purchasing an additional 22,443 shares during the quarter. Vanguard Group Inc. owned about 14.22% of National Health Investors worth $317,063,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Guggenheim Capital LLC grew its position in shares of National Health Investors by 11.4% in the 2nd quarter. Guggenheim Capital LLC now owns 12,484 shares of the real estate investment trust’s stock valued at $654,000 after purchasing an additional 1,279 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of National Health Investors by 5.7% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,944 shares of the real estate investment trust’s stock valued at $1,127,000 after purchasing an additional 1,190 shares during the period. MetLife Investment Management LLC grew its position in shares of National Health Investors by 2.0% in the 2nd quarter. MetLife Investment Management LLC now owns 22,328 shares of the real estate investment trust’s stock valued at $1,170,000 after purchasing an additional 429 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its position in National Health Investors by 36.2% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 14,743 shares of the real estate investment trust’s stock worth $757,000 after acquiring an additional 3,916 shares during the last quarter. Finally, Teacher Retirement System of Texas boosted its position in National Health Investors by 4.7% during the 3rd quarter. Teacher Retirement System of Texas now owns 35,964 shares of the real estate investment trust’s stock worth $1,847,000 after acquiring an additional 1,628 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at National Health Investors
In other National Health Investors news, Director Charlotte A. Swafford purchased 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The shares were acquired at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the purchase, the director now owns 110,185 shares in the company, valued at $6,466,757.65. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 8.21% of the stock is owned by company insiders.
National Health Investors Trading Up 1.9 %
National Health Investors Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 3rd. Investors of record on Thursday, March 28th will be paid a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 5.82%. The ex-dividend date is Wednesday, March 27th. National Health Investors’s dividend payout ratio (DPR) is presently 115.02%.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on the company. Wells Fargo & Company raised National Health Investors from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $55.00 to $63.00 in a research report on Monday, February 26th. BMO Capital Markets raised National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price target for the company in a research report on Tuesday, March 12th. StockNews.com raised National Health Investors from a “hold” rating to a “buy” rating in a research report on Monday. Deutsche Bank Aktiengesellschaft assumed coverage on National Health Investors in a research report on Tuesday, January 30th. They set a “buy” rating and a $69.00 price target for the company. Finally, Wedbush upped their price target on National Health Investors from $64.00 to $66.00 and gave the stock an “outperform” rating in a research report on Monday, March 18th. Four equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $59.22.
National Health Investors Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
- Five stocks we like better than National Health Investors
- Airline Stocks – Top Airline Stocks to Buy Now
- Best Bear Market Funds: Top 3 Investment Options to Consider
- 3 Fintech Stocks With Good 2021 Prospects
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Mid-Cap Stocks to Outperform the Market This Cycle
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI – Free Report).
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.